(Q38080006)

28 August 2017

title

Future viable models of psychiatry drug discovery in pharma (English)

1 reference

28 August 2017

0 references

1 reference

Stacey J Sukoff Rizzo

1

1 reference

28 August 2017

Jeremy R Edgerton

2

1 reference

28 August 2017

Zoë A Hughes

3

1 reference

28 August 2017

Nicholas J Brandon

4

1 reference

28 August 2017

publication date

7 February 2013

1 reference

Journal of Biomolecular Screening

28 August 2017

published in

1 reference

28 August 2017

volume

18

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

509-521

1 reference

CNS drug development. Part I: The early period of CNS drugs

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Metabolites: novel therapeutics or "me-too" drugs? Using desvenlafaxine as an example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Desvenlafaxine: another "me too" drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Principles of early drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

How were new medicines discovered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Trial watch: Phase II failures: 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Phase III and submission failures: 2007–2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Target deconvolution strategies in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Neuropsychopharmacology at the new millennium: new industry directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Removing obstacles in neuroscience drug discovery: the future path for animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Preclinical behavioral models for predicting antipsychotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Behavioral indices in antipsychotic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Animal models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Association within a family of a balanced autosomal translocation with major mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Linking neurodevelopmental and synaptic theories of mental illness through DISC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Lack of persistent effects of ketamine in rodent models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Target site occupancy: emerging generalizations from clinical and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

The development, past achievements, and future directions of brain PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

High-performance liquid chromatography/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Antipsychotic dosing: how much but also how often?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Inverted-U-shaped dopamine actions on human working memory and cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Believe it or not: how much can we rely on published data on potential drug targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Evaluation of animal models of neurobehavioral disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Negative results are published

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Deep brain stimulation for movement and other neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Neuronal oscillations in cortical networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Neuronal gamma-band synchronization as a fundamental process in cortical computation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Sensory processing in autism: a review of neurophysiologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Breakdown of long-range temporal correlations in theta oscillations in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

EEG dynamics in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Variability of the relationship between electrophysiology and BOLD-fMRI across cortical regions in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Gamma frequency-range abnormalities to auditory stimulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Abnormal neural oscillations and synchrony in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

The origin of extracellular fields and currents--EEG, ECoG, LFP and spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Close temporal coupling of neuronal activity and tissue oxygen responses in rodent whisker barrel cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Changes in reward-related signals in the rat nucleus accumbens measured by in vivo oxygen amperometry are consistent with fMRI BOLD responses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113475871

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE10821

Identifiers

DOI

10.1177/1087057113475871

1 reference

28 August 2017

1 reference